A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
Iambic Therapeutics, Inc
National Cancer Institute (NCI)
Stemline Therapeutics, Inc.
Wake Forest University Health Sciences
NRG Oncology
Mayo Clinic
Institut Cancerologie de l'Ouest
Weill Medical College of Cornell University
InSightec
Brigham and Women's Hospital
M.D. Anderson Cancer Center
MedSIR
MedSIR
Yale University
Hoffmann-La Roche
Baptist Health South Florida
UMC Utrecht
Thomas Jefferson University
City of Hope Medical Center
Roswell Park Cancer Institute
AstraZeneca
Sapience Therapeutics
Barbara Ann Karmanos Cancer Institute
Adela, Inc